top of page

EADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic Pruritis

Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on the efficacy and safety of abrocitinib for prurigo nodularis in chronic pruritis.

11 views0 comments


bottom of page